China Acute Myocardial Infarction Registry (CAMIRegistry)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01874691|
Recruitment Status : Completed
First Posted : June 11, 2013
Last Update Posted : January 25, 2018
|Condition or disease|
|Acute Myocardial Infarction|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||20000 participants|
|Target Follow-Up Duration:||2 Years|
|Official Title:||China Acute Myocardial Infarction Registry|
|Actual Study Start Date :||January 2013|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
acute myocardial infarction
acute myocardial infarction including ST-elevation and non ST-elevation myocardial infarction
- In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China [ Time Frame: the duration of hospital stay, an expected average of 2 weeks ]Different-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.
- The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals [ Time Frame: 24 hours ]In different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?
- provoking factors of Chinese patients with AMI across different areas and different population in China [ Time Frame: 24 hours ]The different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.
- the in-hospital cost of Chinese patients with acute myocardial infarction [ Time Frame: the duration of hospital stay, an expected average of 2 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01874691
|Beijing, Beijing, China, 100037|
|Study Chair:||Yuejin Yang, MD.||Fuwai Hospital, Chinse Academy of Medical Sciences|